-+ 0.00%
-+ 0.00%
-+ 0.00%

Hyundai Bioscience top holder CnPharm cuts shares under pledge contracts to 7.76% from 7.92%

PUBT·09/30/2026 08:04:23
Listen to the news
Hyundai Bioscience top holder CnPharm cuts shares under pledge contracts to 7.76% from 7.92%
  • CnPharm filed an amended large-shareholding report for Hyundai Bioscience, citing changes to stock-pledge contracts.
  • Total stake held steady at 11,546,001 shares, or 11.96%, as of Sept. 30.
  • Voting rights also remained unchanged at 9,746,797 votes, or 10.10%.
  • Shares subject to major contracts fell to 7,486,806 shares, or 7.76%, from 7,641,806 shares, or 7.92%.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hyundai Bioscience Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20260930000523), on September 30, 2026, and is solely responsible for the information contained therein.